Patents by Inventor Nabil Rizk

Nabil Rizk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Extended release methazolamide formulation
    Patent number: 11504358
    Abstract: A once-a-day controlled release oral dosage form of methazolamide is provided. The dosage form comprises a therapeutically effective amount of methazolamide and a high molecular weight binder. The dosage is configured for once-daily administration to a subject in need thereof, and releases methazolamide over a period of about twenty-four hours.
    Type: Grant
    Filed: August 4, 2021
    Date of Patent: November 22, 2022
    Assignee: Effcon Laboratories, Inc.
    Inventor: Nabil Rizk
  • Extended Release Methazolamide Formulation
    Publication number: 20220160684
    Abstract: A once-a-day controlled release oral dosage form of methazolamide is provided. The dosage form comprises a therapeutically effective amount of methazolamide and a high molecular weight binder. The dosage is configured for once-daily administration to a subject in need thereof, and releases methazolamide over a period of about twenty-four hours.
    Type: Application
    Filed: August 4, 2021
    Publication date: May 26, 2022
    Inventor: Nabil Rizk
  • Extended release methazolamide formulation
    Patent number: 11103485
    Abstract: A once-a-day controlled release oral dosage form of methazolamide is provided. The dosage form comprises a therapeutically effective amount of methazolamide and a high molecular weight binder. The dosage is configured for once-daily administration to a subject in need thereof, and releases methazolamide over a period of about twenty-four hours.
    Type: Grant
    Filed: November 14, 2019
    Date of Patent: August 31, 2021
    Assignee: Effcon Laboratories, Inc.
    Inventor: Nabil Rizk
  • Extended Release Methazolamide Formulation
    Publication number: 20200253938
    Abstract: A once-a-day controlled release oral dosage form of methazolamide is provided. The dosage form comprises a therapeutically effective amount of methazolamide and a high molecular weight binder. The dosage is configured for once-daily administration to a subject in need thereof, and releases methazolamide over a period of about twenty-four hours.
    Type: Application
    Filed: November 14, 2019
    Publication date: August 13, 2020
    Inventor: Nabil Rizk
  • Extended release methazolamide formulation
    Patent number: 10493063
    Abstract: A once-a-day controlled release oral dosage form of methazolamide is provided. The dosage form comprises a therapeutically effective amount of methazolamide and a high molecular weight binder. The dosage is configured for once-daily administration to a subject in need thereof, and releases methazolamide over a period of about twenty-four hours.
    Type: Grant
    Filed: May 7, 2018
    Date of Patent: December 3, 2019
    Assignee: Effcon Laboratories, Inc.
    Inventor: Nabil Rizk
  • Extended Release Methazolamide Formulation
    Publication number: 20190076408
    Abstract: A once-a-day controlled release oral dosage form of methazolamide is provided. The dosage form comprises a therapeutically effective amount of methazolamide and a high molecular weight binder. The dosage is configured for once-daily administration to a subject in need thereof, and releases methazolamide over a period of about twenty-four hours.
    Type: Application
    Filed: May 7, 2018
    Publication date: March 14, 2019
    Inventor: Nabil Rizk
  • Extended release methazolamide formulation
    Patent number: 9980946
    Abstract: A once-a-day controlled release oral dosage form of methazolamide is provided. The dosage form comprises a therapeutically effective amount of methazolamide and a high molecular weight binder. The dosage is configured for once-daily administration to a subject in need thereof, and releases methazolamide over a period of about twenty-four hours.
    Type: Grant
    Filed: June 13, 2017
    Date of Patent: May 29, 2018
    Assignee: EFFCON LABORATORIES, INC.
    Inventor: Nabil Rizk
  • HANDHELD APPARATUS TO DETERMINE THE VIABILITY OF A BIOLOGICAL TISSUE
    Publication number: 20110224518
    Abstract: The present invention provides for a handheld apparatus for in vivo examination of the viability of a biological tissue.
    Type: Application
    Filed: July 22, 2009
    Publication date: September 15, 2011
    Inventors: Jaafar Tindi, Farah Khan, Christopher D. Hue, Chinedu Chukuigwe, Saumya Banerjee, Rohan Shah, Alina Levchuck, Marom Bikson, Luis Cardoso, Prasad Adusumilli, Nabil Rizk, Luis Carlos Oliveira, Varun Bansai
  • Software debug support for cache flush with access to external data location(s) through debug port
    Publication number: 20070006042
    Abstract: A processor receives one or more debug commands through a debug port to help debug software being executed by the processor. In response to a first one or more of the debug commands, the processor stops execution of the software, and flushes data from cache memory of the processor to one or more data locations external to the processor. In response to a second one or more of the debug commands, the processor accesses one or more data locations external to the processor, and resumes execution of the software.
    Type: Application
    Filed: June 30, 2005
    Publication date: January 4, 2007
    Applicant: International Business Machines Corporation
    Inventors: Bruce Beukema, Alexander Mesh, Nabil Rizk, Robert Shearer, Charles Wait